Bristol-Myers Squibb to Hold Investor Day on April 2
February 19 2020 - 6:59AM
Business Wire
Bristol-Myers Squibb Company (NYSE: BMY) today announced that it
will hold an Investor Day in New York City on Thursday, April 2,
2020. Giovanni Caforio, M.D., chairman and chief executive officer,
and members of the leadership team will discuss the Company’s
strategy, pipeline and business opportunities.
The event will be webcast simultaneously at
http://investor.bms.com, with materials related to the presentation
available at the start of the live webcast. A replay and archived
edition of the presentation will be available following the
event.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube, Facebook, and
Instagram.
Celgene and Juno Therapeutics are wholly owned subsidiaries of
Bristol-Myers Squibb Company. In certain countries outside the
U.S., due to local laws, Celgene and Juno Therapeutics are referred
to as, Celgene, a Bristol-Myers Squibb company and Juno
Therapeutics, a Bristol-Myers Squibb company.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200219005130/en/
Media: media@bms.com 609-252-3345
Investors: Tim Power, 609-252-7509, timothy.power@bms.com Nina
Goworek, 908-673-9711, ngoworek@celgene.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024